(Companies: Merck & Co. Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, Johnson & Johnson Ltd. and Pfizer, Inc.)
The global anti-hypertensive drugs market was valued at about $13.8 billion in 2018. North America was the largest region in the anti-hypertensive drugs market. This region is expected to remain the largest during the next five years.
View Complete Report @ https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report
The anti-hypertensive drugs market consists of sales of anti-hypertensive drugs and related services. These drugs are re used to prevent heart failure, kidney failure and acute stroke induced by hypertension. Some of the major anti-hypertensive drugs include Diuretics, Angiotensin-converting enzyme (ACE) inhibitors, and Angiotensin II receptor antagonists.
The global anti-hypertensive drugs market was valued at about $13.8 billion in 2018 and is expected to decline to $9.72 billion at a rate of approximately -8.4% through 2022. Low awareness of the antihypertensive drugs amongst the population is one of the major restraints in the anti-hypertensive drugs market.
However, sedentary lifestyle is a major driver for the growth of the anti-hypertensive drugs market. Consumption of junk food, lack of proper healthy and balanced diet, lack of proper sleep due to irregular work shifts have contributed to the increase in hypertension. Hypertension is the underlying factor for at least 45% of deaths due to heart disease and 51% of deaths due to stroke. Once the patient is diagnosed of hypertension, patients are required to use the drugs to control hypertension based on the severity of the condition. This creates a sustainable demand for the product and acts as a prominent driver for the growth of the market.
Of late, there has been rise in use of combination therapies compared to monotherapy treatment. Monotherapy is the treatment of a hypertension with a single drug, while the use of combinations of drugs (Combination Therapy) allows for action on several different hypertensive mechanisms. When we combine the two drugs with different mechanisms of action, the effect is two to five times greater than monotherapy. Thus, the use of combination therapy provides greater protection to a target organ than increasing the dose of monotherapy. The trend of using combination therapy is thus more effective and is being widely accepted as well.
Place a Purchase Order of Complete Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2410
Major players in the market are Merck & Co. Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, Johnson & Johnson Ltd. and Pfizer, Inc. AstraZeneca plc is an English-Swedish multinational pharmaceutical and biopharmaceutical company.
Few Points From Table Of Contents:
4. Anti-Hypertensive Drugs Market Segmentation
4.1. Global Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Diuretics
Angiotensin Receptor Blockers (ARBs)
Angiotensin Converting Enzyme (ACE) Inhibitors
Beta Blockers
Alpha Blockers
Calcium Channel Blockers
Renin Inhibitors
Vasodilators
4.2. Global Anti-Hypertensive Drugs Market, Segmentation By Disease source, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Primary Hypertension
Secondary Hypertension
4.3. Global Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Hospitals
Clinics
Homecare
5. Anti-Hypertensive Drugs Market Regional And Country Analysis
5.1. Global Anti-Hypertensive Drugs Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
5.2. Global Anti-Hypertensive Drugs Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
6. Asia-Pacific Anti-Hypertensive Drugs Market
6.1. Asia-Pacific Anti-Hypertensive Drugs Market Overview
6.2. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
7. China Anti-Hypertensive Drugs Market
7.1. China Anti-Hypertensive Drugs Market Overview
7.2. China Anti-Hypertensive Drugs Market, Segmentation By Therapeutics, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion
7.3. China Anti-Hypertensive Drugs Market, Segmentation By End users, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion
Request A Sample of this research report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2410&type=smp
About The Business Research Company
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Media Contact
Company Name: The Business Research Company
Contact Person: Nitin
Email: Send Email
Phone: 08897263534
Address:1st Floor, Anshu Colors Building, Road Number 1 Park View Enclave, Jubilee Hills
City: Hyderabad 500033
State: Telengana
Country: India
Website: https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report